Search research articles
Contact Us
Filters
Showing results (121-130 of 210) with videos related to
Page
of 21
Sort By:
Journal of the Neurological Sciences
|
June 7, 2025
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis
Federica Novarella, Valerio Nicolella, Mariano Fiorenza, et al.
Multiple Sclerosis and Related Disorders
|
April 29, 2022
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis
Emanuela Zappulo, Antonio Riccardo Buonomo, Marcello Moccia, et al.
Expert Opinion on Drug Delivery
|
March 1, 2016
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study
Damiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 13, 2023
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study
Giancarlo Comi, Letizia Leocani, Luigi Ferini-Strambi, et al.
Brain Sciences
|
July 19, 2020
A Multiple <i>N</i>-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis
Francesca Nuti, Feliciana Real Fernandez, Giuseppina Sabatino, et al.
European Radiology
|
January 14, 2022
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease
Mario Tranfa, Mario Tortora, Giuseppe Pontillo, et al.
Clinical Immunology (Orlando, Fla.)
|
August 22, 2017
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a
Roberta Lanzillo, Fortunata Carbone, Mario Quarantelli, et al.
Frontiers in Chemistry
|
July 7, 2022
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis
Agnieszka Staśkiewicz, Michael Quagliata, Feliciana Real-Fernandez, et al.
Radiology
|
September 23, 2025
Prevalence and Incidence of Paramagnetic Rim Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis
Mario Tranfa, Valeria Cantoni, Roberta Green, et al.
Brain Sciences
|
April 3, 2021
Public Engagement and Neurology: An Update
Luigi Lavorgna, Francesco Brigo, Sabrina Esposito, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 210) with videos related to
Sort By:
Page
of 21
Journal of the Neurological Sciences
|
June 7, 2025
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis
Federica Novarella, Valerio Nicolella, Mariano Fiorenza, et al.
Multiple Sclerosis and Related Disorders
|
April 29, 2022
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis
Emanuela Zappulo, Antonio Riccardo Buonomo, Marcello Moccia, et al.
Expert Opinion on Drug Delivery
|
March 1, 2016
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study
Damiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 13, 2023
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study
Giancarlo Comi, Letizia Leocani, Luigi Ferini-Strambi, et al.
Brain Sciences
|
July 19, 2020
A Multiple <i>N</i>-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis
Francesca Nuti, Feliciana Real Fernandez, Giuseppina Sabatino, et al.
European Radiology
|
January 14, 2022
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease
Mario Tranfa, Mario Tortora, Giuseppe Pontillo, et al.
Clinical Immunology (Orlando, Fla.)
|
August 22, 2017
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a
Roberta Lanzillo, Fortunata Carbone, Mario Quarantelli, et al.
Frontiers in Chemistry
|
July 7, 2022
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis
Agnieszka Staśkiewicz, Michael Quagliata, Feliciana Real-Fernandez, et al.
Radiology
|
September 23, 2025
Prevalence and Incidence of Paramagnetic Rim Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis
Mario Tranfa, Valeria Cantoni, Roberta Green, et al.
Brain Sciences
|
April 3, 2021
Public Engagement and Neurology: An Update
Luigi Lavorgna, Francesco Brigo, Sabrina Esposito, et al.
Page
of 21